HealthPhoto: Hindu HealthSupreme Court Seeks Trade Margin Cap on All Essential Medicines
The Supreme Court questioned why the government’s proposed 30% trade-margin cap on patented and non-patented cancer medicines cannot be extended to all medicines and medical products. The court emphasized that the government must ensure that medicines approved under the Drug Price Control Order (DPCO), which have legally regulated prices, are accessible to patients.
Hindu Health·



